Why not wait and see what management announces pri
Post# of 15624
(Total Views: 411)
Posted On: 03/14/2019 10:02:44 AM
Why not wait and see what management announces prior to the stockholder meeting. They are expected to detail their R/S plans. The only solid information we have concerning their intentions is this latest filing which clearly indicates they are taking action to reduce the chance of the R/S not passing a vote.
I would be shocked if the spit is not at least 100 to 1. However, if they can get investors attention in the next few months and obtain additional financing, they may wait until year end before pulling the trigger or simply choose to not implement the R/S. As to stock price, so many factors will determine what may occur it is useless to try and project........although it can be fun.
Back to the R/S, the 100 to 1 assumes they are unable to get any additional capital. If they can and then are able to get a good report on the tablet testing the share price may rise sufficiently to reduce the ratio. Of course, the new investor(s) may have a say in whether there is an R/S and at what ratio.
Lastly, the "threat" of a R/S may be far less important to an investor than it is to most of us. An investor will do their due diligence and before proceeding to the next level know and likely dictate the R/S details. I have always viewed the R/S as another Company option if all else fails.
While we could all be very disappointed at the outcome I am still betting the Company management, while protecting themselves first, is looking out for the shareholders too.
I would be shocked if the spit is not at least 100 to 1. However, if they can get investors attention in the next few months and obtain additional financing, they may wait until year end before pulling the trigger or simply choose to not implement the R/S. As to stock price, so many factors will determine what may occur it is useless to try and project........although it can be fun.
Back to the R/S, the 100 to 1 assumes they are unable to get any additional capital. If they can and then are able to get a good report on the tablet testing the share price may rise sufficiently to reduce the ratio. Of course, the new investor(s) may have a say in whether there is an R/S and at what ratio.
Lastly, the "threat" of a R/S may be far less important to an investor than it is to most of us. An investor will do their due diligence and before proceeding to the next level know and likely dictate the R/S details. I have always viewed the R/S as another Company option if all else fails.
While we could all be very disappointed at the outcome I am still betting the Company management, while protecting themselves first, is looking out for the shareholders too.
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼